President Trump’s new drug platform, TrumpRx, appears to overlap with the business interests of his son, Donald Trump Jr.— who sits on the board of BlinkRx, a company reportedly pitching to help run the site. This raises serious questions about presidential self-dealing. Yet major networks and national papers have barely covered the story. The public deserves accountability and transparency — not silence — when government power and private profit intertwine. Add your name to demand that national news outlets investigate and report on the TrumpRx scandal.